Exabis Library
Welcome to the e-CCO Library!
OP19: Gaps between ECCO quality standards of care and the real world: the E-QUALITY survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP19: Perinatal factors do not affect paediatric Inflammatory Bowel Disease risk: A Scottish nationwide cohort study using administrative health data 1981-2017
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
OP19: Perinatal factors do not affect paediatric Inflammatory Bowel Disease risk: A Scottish nationwide cohort study using administrative health data 1981-2017
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
OP20 The gut microbiota during biological therapy for inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP20: Mucosal micoRNA profiles predict response to autologous stem-cell transplantation in Crohn’s disease
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP20: Mucosal microRNA profiles predict response to autologous stem-cell transplantation in Crohn’s Disease.
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
OP20: Perianal fistulas are characterised by expansion of interleukin-22 producing invariant natural killer T-cells and CD4+ T-cells which drive dysregulation of the extracellular matrix
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP20: Postoperative endoscopic recurrence after resection of Crohn’s terminal ileitis with Kono-S or side-to-side functional end anastomosis: results of a Multicenter Prospective Randomized Trial
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
OP20: Risk and predictors of surgery in a newly diagnosed cohort of IBD patients in the biologic era: Results from the EpidemIBD study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
OP20: The effects of upadacitinib on ulcerative colitis symptom resolution and fatigue normalization in patients with moderately to severely active ulcerative colitis: Phase 3 U-ACHIEVE and U-ACCOMPLISH results
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
OP20: The effects of upadacitinib on ulcerative colitis symptom resolution and fatigue normalization in patients with moderately to severely active ulcerative colitis: Phase 3 U-ACHIEVE and U-ACCOMPLISH results
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP21 Positivity thresholds of total infliximab and adalimumab anti-drug antibody assay: The prevalence of clearing and transient anti-drug antibodies in a national therapeutic drug monitoring service
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP21: ABX464 is safe and efficacious in a proof of concept study in ulcerative colitis patients
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
OP21: ABX464 is safe and efficacious in a proof-of-concept study in ulcerative colitis patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
OP21: COVID-19 morbidity/mortality and vaccination against SARS-CoV-2 in patients with Inflammatory Bowel Disease in Poland: Nationwide Data
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
OP21: COVID-19 morbidity/mortality and vaccination against SARS-CoV-2 in patients with Inflammatory Bowel Disease in Poland: Nationwide Data
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
OP21: COVID-19 vaccine-induced antibody responses are impaired in Inflammatory Bowel Disease patients treated with infliximab, ustekinumab or tofacitinib, but not thiopurines or vedolizumab
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
OP21: Positivity thresholds of a total infliximab and adalimumab anti-drug antibody assay: The prevalence of clearing and transient anti-drug antibodies in a national therapeutic drug monitoring service
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
OP21: Positivity thresholds of a total infliximab and adalimumab anti-drug antibody assay: The prevalence of clearing and transient anti-drug antibodies in a national therapeutic drug monitoring service
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
OP21: Predictive value of Milan Ultrasound Criteria in Ulcerative Colitis: A prospective observational cohort study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM